Percutaneous radiofrequency ablation of hepatocellular carcinoma in the presence of portal vein thrombosis

Clinical Imaging

Volumn 27, Issue 6, 2003, Pages 417-420

  Neeman, Ziv ^a   Libutti, Steven K ^b   Patti, Jay W ^a,c   Wood, Bradford J ^a,d  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Hepatocellular carcinoma (HCC); Portal vein thrombosis (PVT); Radiofrequency ablation (RFA)

Indexed keywords

ABLATION; PATIENT TREATMENT; TUMORS;

PORTAL VEIN THROMBOSIS (PVT);

MEDICAL IMAGING;

CIPROFLOXACIN; METRONIDAZOLE;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ASCITES; CARCINOMA IN SITU; CASE REPORT; CATHETER ABLATION; CLINICAL FEATURE; COLON CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DRUG CONTRAINDICATION; FOLLOW UP; HUMAN; INFECTION; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MEDICAL EXAMINATION; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL VEIN; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; TOMOGRAPHY; TREATMENT OUTCOME; VEIN THROMBOSIS;

EID: 0142258082     PISSN: 08997071     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-7071(03)00015-9     Document Type: Article

References (14)

1. Janssen H.L. Changing perspective in portal vein thrombosis. Scand J Gastroenterol Suppl. 232:2000;69-73.
2. Valla D.C., Condat B. Portal vein thrombosis in adults: pathophysiology, pathogenesis and management. J Hepatol. 32:2000;865-871.
3. Okada S., Okazaki N., Nose H., Yoshimori M., Aoki K. Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Hepatology. 16:1992;112-117.
4. Akashi Y., Korceda C., Enomoto S., Uchiyama S., Mizuno T., Shiozaki Y., Sameshima Y., Inoue K. Prognosis of unresectable hepatocellular carcinoma: an evaluation based on multivariate analysis of 90 cases. Hepatology. 14:1991;262-268.
5. Pentecost M.J., Daniels J.R., Teitelbaum G.P., Stanley P. Hepatic chemoembolization: safety with portal vein thrombosis. J Vasc Interv Radiol. 4:1993;347-351.
6. Allison D.J., Jordan H., Hennessy O. Therapeutic embolisation of the hepatic artery: a review of 75 procedures. Lancet. 1(16):1985;595-599.
7. Lee H.S., Kim J.S., Choi I.J., Chung J.W., Park J.H., Kim C.Y. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study. Cancer. 79:1997;2087-2094.
8. Solbiati L., Ierace T., Goldberg S.N., Sironi S., Livraghi T., Fiocca R., Servadio G., Rizzatto G., Mueller P.R., Del Maschio A., Gazelle G.S. Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. Radiology. 202:1997;195-203.
9. Rossi S., Di Stasi M., Buscarini E., Quaretti P., Garbagnati F., Squassante L., Paties C.T., Silverman D.E., Buscarini L. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol. 167:1996;759-768.
10. Catalano O., Esposito M., Nunziata A., Siani A. Multiphase helical CT findings after percutaneous ablation procedures for hepatocellular carcinoma. Abdominal Imaging. 25:2000;607-614.
11. Francica G., Marone G., Solbiati L., D'Angelo V., Siani A. Hemobilia, intrahepatic hematoma and acute thrombosis with cavernomatous transformation of the portal vein after percutaneous thermoablation of a liver metastasis. Eur Radiol. 10:2000;926-929.
12. Montorsi M., Santambrogio R., Bianchi P., Opocher E., Zuin M., Bertolini E., Bruno S., Podda M. Radiofrequency interstitial thermal ablation of hepatocellular carcinoma in liver cirrhosis. Role of the laparoscopic approach. Surg Endosc. 15:2001;141-145.
13. Golberg S.N., Hahn P.F., Tanabe K.K., Mueller P.R., Schima W., Athanasoulis C.A., Compton C.C., Solbiati L., Gazelle G.S. Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis? J Vasc Interv Radiol. 9:1998;101-111.
14. Patterson F.J., Scudamore C.H., Owen D.A., Nagy A.G., Buczkowski A.K. Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size. Ann Surg. 227:1998;559-565.